Correlation Between Northwest Biotherapeutics and VBI Vaccines

Can any of the company-specific risk be diversified away by investing in both Northwest Biotherapeutics and VBI Vaccines at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Northwest Biotherapeutics and VBI Vaccines into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Northwest Biotherapeutics and VBI Vaccines, you can compare the effects of market volatilities on Northwest Biotherapeutics and VBI Vaccines and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Northwest Biotherapeutics with a short position of VBI Vaccines. Check out your portfolio center. Please also check ongoing floating volatility patterns of Northwest Biotherapeutics and VBI Vaccines.

Diversification Opportunities for Northwest Biotherapeutics and VBI Vaccines

0.76

Correlation Coefficient

Northwest Biotherapeutics  VBI Vaccines

Poor diversification

The 3 months correlation between Northwest and VBI is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding Northwest Biotherapeutics and VBI Vaccines in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on VBI Vaccines and Northwest Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Northwest Biotherapeutics are associated (or correlated) with VBI Vaccines. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of VBI Vaccines has no effect on the direction of Northwest Biotherapeutics i.e., Northwest Biotherapeutics and VBI Vaccines go up and down completely randomly.

Pair Corralation between Northwest Biotherapeutics and VBI Vaccines

Given the investment horizon of 90 days Northwest Biotherapeutics is expected to generate 0.14 times more return on investment than VBI Vaccines. However, Northwest Biotherapeutics is 7.24 times less risky than VBI Vaccines. It trades about -0.07 of its potential returns per unit of risk. VBI Vaccines is currently generating about -0.04 per unit of risk. If you would invest  33.00  in Northwest Biotherapeutics on September 27, 2024 and sell it today you would lose (7.00) from holding Northwest Biotherapeutics or give up 21.21% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Northwest Biotherapeutics  vs.  VBI Vaccines

Northwest Biotherapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Northwest Biotherapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's fundamental drivers remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

VBI Vaccines

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days VBI Vaccines has generated negative risk-adjusted returns adding no value to investors with long positions. Even with uncertain performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Pair Trading with Northwest Biotherapeutics and VBI Vaccines

The main advantage of trading using opposite Northwest Biotherapeutics and VBI Vaccines positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Northwest Biotherapeutics position performs unexpectedly, VBI Vaccines can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VBI Vaccines will offset losses from the drop in VBI Vaccines' long position.

The idea behind Northwest Biotherapeutics and VBI Vaccines pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.